3-Ethynylaniline CAS 54060-30-9 Ịdị ọcha>99.0% (GC) Erlotinib Hydrochloride Intermediate

Nkọwa dị mkpirikpi:

Aha ọgwụ: 3-Ethynylaniline

Ụdị okwu: 3-Aminophenylacetylene

Ọnọdụ: 54060-30-9

Dị ọcha:> 99.0% (GC)

Ọdịdị: Ìhè Yellow ruo Brown Liquid

Ọkara nke Erlotinib Hydrochloride (CAS: 183319-69-9)

Kpọtụrụ: Dr. Alvin Huang

Mobile/Wechat/WhatsApp: +86-15026746401

E-Mail: alvin@ruifuchem.com

Zitere anyị email

Nkọwa ngwaahịa

Ngwaahịa ndị emetụtara

Mkpado ngwaahịa

Nkọwa:

Onye na-emepụta ihe na onye na-ebubata Erlotinib Hydrochloride Intermediates
Erlotinib Hydrochloride CAS 183319-69-9
3-Ethynylaniline CAS 54060-30-9
6,7-Bis (2-Methoxyethoxy) -3H-Quinazolin-4-otu CAS 179688-29-0
Please contact: alvin@ruifuchem.com

Njirimara kemịkalụ:

Aha Chemical	3-Ethynylaniline
Ụdị okwu	3-Aminophenylacetylene
Nọmba CAS	54060-30-9
Nọmba CAT	RF-PI2241
Ọnọdụ Ahịa	Na Akụrụngwa, Ike nrụpụta 50MT / ọnwa
Usoro ihe omimi	C8H7N
Ibu molekụla	117.15
Mmetụta	Mmetụta ikuku, Mmetụta ọkụ
Ebe esi nri	120 ℃/20 mmHg
Mmiri Solubility	Na-adịghị edozi n'ime mmiri
Ụdị	Ruifu Chemical

Nkọwapụta:

Ihe	Nkọwapụta
Ọdịdị	Icha odo odo gaa na mmiri mmiri Brown
Ụzọ ịdị ọcha / nyocha	> 99.0% (GC)
Mmiri nke Karl Fischer	<0.50%
Ihe fọdụrụ na mgbanye	<0.20%
Mgbakọta adịghị ọcha	<1.00%
Nnukwu ike ndọda (20/20 ℃)	1.041-1.048
Ntụgharị ntụgharị n20/D	1.614-1.6195
Spectrum infrared	Dabara na Ọdịdị
Ọnụ ego nke Proton NMR Spectrum	Dabara na Ọdịdị
Nlele ọkọlọtọ	Standardkpụrụ ụlọ ọrụ
Ojiji	Ndị na-emepụta ọgwụ na etiti;Erlotinib Hydrochloride Intermediate

Ngwungwu & Nchekwa:

ngwugwu: Klas Fluorinated, 25kg/Drum, ma ọ bụ dị ka ndị ahịa chọrọ

Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe site na ìhè na mmiri mmiri

Uru:

Ajụjụ:

Ngwa:

3-Ethynylaniline, nke a makwaara dị ka 3-Aminophenylacetylene (CAS: 54060-30-9) na-eji dị ka onye na-ahụ maka ọgwụ.3-Ethynylaniline bụ etiti Erlotinib Hydrochloride (CAS: 183319-69-9).Erlotinib Hydrochloride bụ obere molecule tyrosine kinase inhibitor nke na-eme mgbanwe na ndị na-anabata uto epidermal, hydrochloride nke erlotinib, ọgwụ ezubere iche.Ndị nchịkwa nri na ọgwụ ọjọọ nke US (FDA) akwadoro erlotinib (Tarceva) yana gemcitabine dịka ọgwụgwọ mbụ maka ọrịa cancer pancreatic dị elu na mpaghara metastatic.A na-ejikarị ya dị ka ọgwụgwọ nke abụọ ma ọ bụ nke atọ maka ọrịa cancer akpa ume na mpaghara ma ọ bụ metstatic na-abụghị obere cell (NSCLC) yana dịka ọgwụgwọ maka ọrịa cancer pancreatic.A na-eji ya dị ka ihe mgbochi tyrosine maka ọgwụgwọ NSCLC.Erlotinib Hydrochloride, quinazoline ewepụtara obere molecule inhibitor nke epidermal growth receptor (EDGFR) tyrosine kinase, ka akwadoro na Nọvemba, 2004, maka ọgwụgwọ ọrịa cancer akpa ume dị elu ma ọ bụ metastatic na-abụghị obere mkpụrụ ndụ.